If you need more lookups,
subscriptions start at $34 USD/month.
Christopher Lindemann Location
Denver, CO, US
Christopher Lindemann Work
2025 -now Executive Director SMDD @ Eli Lilly and Company
2023 -2025 Associate Vice President, Oncology CMC @ Eli Lilly and Company
2021 -2023 Senior Director, CMC Pharmaceutics @
2020 -2021 Director, CMC Pharmaceutics @
2018 -2020 Director, Pharmaceutical Development @ Peloton Therapeutics
2014 -2018 Founder and President @ Focus Pharmaceutics, LLC
2006 -2014 Senior Research Scientist @ Array BioPharma
2004 -2006 Scientist I @
2002 -2004 Scientist I @
1999 -2002 Staff Chemist @
Christopher Lindemann Education
University of Wyoming
M.S. (Chemistry)
1997-1999
University of Wyoming
B.S. (Chemistry)
1993-1997
Christopher Lindemann Skills
HPLC
Analytical Chemistry
Chromatography
Chemistry
Drug Discovery
Medicinal Chemistry
Drug Development
Biotechnology
Organic Synthesis
Pharmaceutical Industry
Organic Chemistry
UV/Vis
LC-MS
Drug Design
GLP
Formulation
GMP
Drug Delivery
Development
Pharmaceutics
Leadership
Good Laboratory Practice Glp
Marketing
Pharmaceutical Project Management
CMC
Project Management
Entrepreneurship
Public Speaking
Standard Operating Procedure Sop
Customer Service
Process Development
Lc Ms
Standard Operating Procedure
Good Laboratory Practice
Christopher Lindemann Summary
Christopher Lindemann, based in Denver, CO, US, is currently a Executive Director SMDD at Eli Lilly and Company. Christopher Lindemann brings experience from previous roles at Eli Lilly and Company, Loxo Oncology at Lilly and Peloton Therapeutics. Christopher Lindemann holds a 1997 - 1999 M.S. in Chemistry @ University of Wyoming. With a robust skill set that includes HPLC, Analytical Chemistry, Chromatography, Chemistry, Drug Discovery and more. Christopher Lindemann has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Christopher Lindemann?
Find contact details for 700 million professionals.